Skip to main content
Vincent Ho, MD, Oncology, Boston, MA

VincentTrien-VinhHoMD

Oncology Boston, MA

Hematologic Oncology

Clinical Director, Allogeneic Hematopoietic Stem Cell Transplantation, Dana-Farber Cancer Institute. Associate Professor of Medicine, Harvard Medical School

Dr. Ho is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ho's full profile

Already have an account?

  • Office

    44 Binney St
    Boston, MA 02115
    Phone+1 617-632-5938
    Fax+1 617-632-5168

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1999
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
  • Harvard Medical School
    Harvard Medical SchoolClass of 1996

Certifications & Licensure

  • RI State Medical License
    RI State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2000 - 2025
  • NH State Medical License
    NH State Medical License 2023 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
    Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Outcome of Autologous Stem Cell Transplantation Following PD-(L)1 Based Salvage Therapy for Multiply Relapsed Patients with Classic Hodgkin Lymphoma
    Vincent T. Ho, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants
    New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
  • We Need to Talk About Zoom Poops
    We Need to Talk About Zoom PoopsMarch 30th, 2021

Grant Support

  • Data Management And Specimen Tracking CoreNational Cancer Institute2009–2011